Bihi Pharmaceuticals develops and commercializes a focused portfolio of ophthalmic and essential medicinal products through structured licensing and distribution partnerships.
The company maintains a deliberately focused product strategy, prioritizing essential medicines aligned with national treatment guidelines and clearly defined public health needs.
Product selection is guided by regulatory feasibility, manufacturing quality, and long-term market sustainability.
Bihi Pharmaceuticals is currently advancing selected ophthalmic and essential medicinal products through licensing, regulatory preparation, and market-entry planning stages.
Detailed product information is shared selectively under confidentiality agreements with qualified partners.